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Introductıon: We sought to determine the possible association of stroke risk
prediction models (CHA2DS2-VASc, CHADS2) and the new R2CHADS2 (The
inclusion of creatinine clearance (CrCL) <60 mL/min to CHADS2) to the markers of
brain ischemia and inﬂammation such as hsCRP and Neutrophil to Lymphocyte Ratio
(NLR) in patients with non-valvular atrial ﬁbrillation (NVAF). We tested the
hypothesis that markers of subclinical brain ischemia (NSE and S100b) are higher in
patients with NVAF having higher stroke risk as determined by risk prediction
models.
Methods: The study population included 92 patients who were seen in our
outpatient clinic. End-stage hepatic or renal disease, malignancy, any prior blood
transfusions, carotid artery disease, prior transient ischemic attack and ischemic or
hemorrhagical stroke and oral anticoagulant usage were excluded from study.
Serum levels of S100B, NSE, hs-CRP were measured by using a commercial
enzyme-linked immunoassay kits and each assay was carried out in duplicate.
S100B, neuron speciﬁc enolase, NSE and Hs-CRP levels were determined by
using sandwich ELISA kits (Human S100B ELISA kit, BioVendor Research and
Diagnostic Products; DRG,NSE ELISA; DRG, HS-CRP).The minimal measurable
concentrations for these detection systems were 50 pg/ml for S100B, 1 ng/ml for
NSE, and 0.1 mg/L for Hs-CRP. Intra and inter assay variabilities for each marker
were 4.4% and 11.2% for NSE, 7.5% and 4.1% for Hs-CRP and 3.8% and 10.1%
for S100b.
Results: The patients were divided into three group according to their
CHA2DS2Vasc score as follows; score under <2, score 3-4,and score >4. There
were no signiﬁcant differences among the groups in terms of Hs-Rcp and NLR. We
showed outstanding ﬁndings in NSE and S100b values that patients with
CHA2DS2VASc scores higher than 4 had signiﬁcantly higher values of brain
damage marker than patients with the scores of below 2 (23.2  15.8 ng/ml vs.
32.6  28.9 ng/ml vs. 44.4 ng/ml  35.4 p¼0.022 and 161  62 pg/ml vs.186 
37 pg/ml vs.189  25 pg/ml p¼0.037,respectively). Serum levels of NSE and
S100b were correlated with CHA2DS2Vasc scores (p¼0.04 r¼0.218 for NSE and
p¼0.03 r¼0.229 for s100b).
Conclussıon: Measurement of these markers may have an additive effect when
evaluating patients’ individual risk of stroke in the setting of NVAF.C148 JACC VoPP-171
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Aim: Interatrial block (IAB) connotes a P wave duration 110 msec on electrocar-
diography (ECG). P-terminal force corresponds to a biphasic P wave with its terminal
negative phase 40 msec x mm in V1 derivation on ECG. IAB and P-terminal force
are closely related parameters and they are accepted as predictors for left atrial
dysfunction, left atrial dilatation, atrial ﬁbrillation and strokes. Left atrial functions in
chronic haemodialysis patients becomes worse in the course of time because of long
standing pressure and volume overload. The aim of this study is to evaluate the
relationship between IAB, P-terminal force and left atrial functions.
Patients and Methods: 68 chronic haemodialysis patients and 60 control subjects
were included in the study. Haemodialysis group had 4213.5 months dialysis period.
Conventional echocardiography and left atrial dynamic functions were measured in all
cases. The subjects with IAB and P-terminal force on ECG were identiﬁed.
Results: Demographic, electrocardiographic and echocardiographic data of study and
control groups is presented in Table 1. Left ventricular size, wall thickness and left
atrial diameters were signiﬁcantly greater in haemodialysis patients than the control
group (p<0.001). 42 (62%) patients had IAB (110 msec) and 45 (66%) patients
had P-terminal force (40 msecxmm) in the haemodialysis group. Left atrial
reservoir, conduit and pump functions were signiﬁcantly lower in the haemodialysis
group than the control group (p<0.001) (Table 2).
Conclusıons: This study showed that decreased left atrial functions in chronic hae-
modialysis patients are closely correlated with IAB and P-terminal force.Table 1. Demographic, electrocardiographic and echocardiographic data of
haemodialysis patients and the control group.
Haemodialysis
group (n¼68)
Control group
(n¼60) P-value
Age 376.1 38.36.5 0.69
Gender(F/M) 38/30 35/25 0.59
SBP (mm Hg) 13515 12515 0.11
DBP (mm Hg) 8212 7411 0.25
LVEDd (mm) 51.54.0 453.9 <0.001
LVESd (mm) 35.44.7 302.6 <0.001
IVSd (mm) 12.21.5 10.11.5 <0.001
LVEF Simpson's (%) 59.99.5 62.18.4 0.12
LA (mm) 42.54.6 32.22.9 <0.001
Interatrial block
(110 msec)(n, %)
42(62) 0 <0.001
P-terminal force (n, %) 45 (66) 8 (13) <0.001
Reservoir function (%) 42.87.8 54.84.3 <0.001
Conduit function (%) 17.74.5 33.43.9 <0.001
Pump function (%) 35.86.5 46.66.4 <0.001
SBP: Systolic blood pressure, DBP: Diastolic blood pressure, LVEDd: Left ventricular end dia-
stolic diameter, LVESd: Left ventricular end systolic diameter, IVSd: Interventricular septum
diastolic diameter, LVEF: Left ventricular ejection fraction, LA: Left atrial diameter
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